Back to Search
KYLE KAMPMAN, MD
MD
Psychiatry Physician
NPI: 1093745085Individual
Specialties, Licenses & Credentials
Psychiatry & Neurology — Addiction Psychiatry
Code: 2084P0802X
MD045520E(PA)
Research & Publications (20)
New medications for the treatment of cocaine dependence.
PMID 19636162·Ann Ist Super Sanita·2009
6-review
The search for medications to treat stimulant dependence.
PMID 18497715·Addict Sci Clin Pract·2008
8-other
A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
PMID 17632217·J Clin Psychopharmacol·2007
2-rct
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
PMID 16697124·Drug Alcohol Depend·2006
2-rct
Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.
PMID 15730354·Addiction·2005
8-other
A pilot trial of topiramate for the treatment of cocaine dependence.
PMID 15283944·Drug Alcohol Depend·2004
4-observational
A pilot trial of olanzapine for the treatment of cocaine dependence.
PMID 12757964·Drug Alcohol Depend·2003
3-trial
A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence.
PMID 12628617·Addict Behav·2003
3-trial
Concurrent cocaine withdrawal alters alcohol withdrawal symptoms.
PMID 12296498·J Addict Dis·2002
4-observational
Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity.
PMID 11297832·Drug Alcohol Depend·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3535 MARKET ST, 3RD FLOOR
PHILADELPHIA, PA 19104 - Phone
- (215) 746-6700
Quick Facts
- NPI
- 1093745085
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile